Post-effective amendment to a registration statement that is not immediately effective upon filing

SEGMENT REPORTING (Details) - Schedule of Segment Reporting Information, by Segment

v3.21.1
SEGMENT REPORTING (Details) - Schedule of Segment Reporting Information, by Segment - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating Segments    
Segment Net Sales:    
Total Net Sales $ 12,117 $ 7,834
Segment Profit (Loss):    
Gross profit (16,935) (24,636)
Long-lived assets    
Long-lived assets 25,680 24,432
Reconciliation    
Segment Profit (Loss):    
Gross profit (16,935) (24,636)
Unallocated corporate expenses (6,405) (5,887)
Non-cash share based compensation (1,652) (1,522)
Depreciation and amortization (1,854) (1,480)
Herbal Brands acquisition related charges (3,015)
Goodwill impairment (1,682)
Loss from operations (28,528) (36,540)
Loss on debt extinguishment 2,360 3,374
Loss on fair value of derivative instrument 657 421
Loss on investments 464 756
Foreign exchange loss 491 1,575
Interest expense 4,455 2,684
Miscellaneous, net (284) 534
Loss from operations before income taxes (36,671) (45,884)
Cannabinoid | Operating Segments    
Segment Net Sales:    
Total Net Sales 2,511 133
Segment Profit (Loss):    
Gross profit (18,798) (25,250)
Long-lived assets    
Long-lived assets 25,485 24,209
Non-Cannabinoid | Operating Segments    
Segment Net Sales:    
Total Net Sales 9,606 7,701
Segment Profit (Loss):    
Gross profit 1,863 614
Long-lived assets    
Long-lived assets 176 207
Other | Operating Segments    
Long-lived assets    
Long-lived assets [1] $ 19 $ 16
[1] “Other” includes long-lived assets primarily in the Company’s corporate offices.